Aurora Cannabis (TSE:ACB) Stock Price Up 19.9% - Time to Buy?

Key Points

• Aurora Cannabis shares surged 19.9% to C$7.06, with trading volume reaching nearly 2 million shares—382% above the average session volume.
• Analyst sentiment is moderately positive: two analysts rate the stock Buy and one rates it Hold, with a consensus target price of C$6.67.
• The company remains unprofitable, reporting a quarterly loss of C$0.07 per share, C$67.55 million in revenue, a negative net margin, and a projected full-year loss of C$0.22 per share.

Aurora Cannabis Inc. (TSE:ACB - Get Free Report) shares shot up 19.9% during mid-day trading on Tuesday. The stock traded as high as C$7.20 and last traded at C$7.06. 1,969,414 shares traded hands during mid-day trading, an increase of 382% from the average session volume of 408,543 shares. The stock had previously closed at C$5.89.

Wall Street Analysts Forecast Growth

ACB has been the topic of several analyst reports. BMO Capital Markets raised Aurora Cannabis to a "hold" rating in a research report on Wednesday, August 5th. ATB Cormark Capital Markets increased their price objective on Aurora Cannabis from C$5.60 to C$7.00 and gave the company a "tender" rating in a research report on Tuesday, October 6th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Aurora Cannabis presently has a consensus rating of "Moderate Buy" and a consensus target price of C$6.67.

Aurora Cannabis Stock Performance

The firm has a market capitalization of C$443.61 million, a price-to-earnings ratio of -3.69 and a beta of 0.64. The stock has a fifty day moving average price of C$5.69 and a 200-day moving average price of C$4.93. The company has a current ratio of 5.36, a quick ratio of 2.48 and a debt-to-equity ratio of 4.30.

Aurora Cannabis (TSE:ACB - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. The firm had revenue of C$67.55 million during the quarter. Aurora Cannabis had a negative net margin of 9.53% and a negative return on equity of 5.21%. As a group, analysts anticipate that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

Aurora Cannabis Company Profile

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty's ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.